Ovarian response to the human chorionic gonadotrophin stimulation test in normal ovulatory women: the impact of regressing corpus luteum

Fertility and Sterility

Volumn 87, Issue 5, 2007, Pages 1122-1130

  Järvelä, Ilkka Y ^a   Niinimäki, Maarit ^a   Martikainen, Hannu ^a   Ruokonen, Aimo ^a   Tapanainen, Juha S ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

17 OHP; progesterone; three dimensional power Doppler; vasculature; VEGF

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; ESTRADIOL; HYDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; STEROID HORMONE; TESTOSTERONE; VASCULOTROPIN;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CELL SECRETION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS LUTEUM; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; DRUG MECHANISM; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MENSTRUAL CYCLE; NORMAL HUMAN; OBSERVATIONAL STUDY; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; OVARY; OVARY BLOOD FLOW; OVARY CYCLE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL; THECA CELL; THREE DIMENSIONAL IMAGING; UNIVERSITY HOSPITAL;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; CHORIONIC GONADOTROPIN; CORPUS LUTEUM; FEMALE; GONADAL STEROID HORMONES; HUMANS; LUTEAL PHASE; OVARY; OVULATION; OVULATION INDUCTION; PROSPECTIVE STUDIES;

EID: 34247476344     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.08.114     Document Type: Article

References (32)

1. Gilling-Smith C., Willis D.S., Beard R.W., and Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79 (1994) 1158-1165
2. Nelson V.L., Legro R.S., Strauss III J.F., and McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13 (1999) 946-957
3. Adams J.M., Taylor A.E., Crowley Jr. W.F., and Hall J.E. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89 (2004) 4343-4350
4. Gilling-Smith C., Story H., Rogers V., and Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 47 (1997) 93-99
5. Ibanez L., Hall J.E., Potau N., Carrascosa A., Prat N., and Taylor A.E. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing. J Clin Endocrinol Metab 81 (1996) 4103-4107
6. Koivunen R.M., Morin-Papunen L.C., Ruokonen A., Tapanainen J.S., and Martikainen H.K. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin. Hum Reprod 16 (2001) 2546-2551
7. Levrant S.G., Barnes R.B., and Rosenfield R.L. A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod 12 (1997) 1416-1420
8. Piltonen T., Koivunen R., Morin-Papunen L., Ruokonen A., Huhtaniemi I.T., and Tapanainen J.S. Ovarian and adrenal steroid production: regulatory role of LH/HCG. Hum Reprod 17 (2002) 620-624
9. Piltonen T., Koivunen R., Perheentupa A., Morin-Papunen L., Ruokonen A., and Tapanainen J.S. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 3769-3775
10. Piltonen T., Koivunen R., Ruokonen A., and Tapanainen J.S. Ovarian age-related responsiveness to human chorionic gonadotropin. J Clin Endocrinol Metab 88 (2003) 3327-3332
11. Carmina E., and Lobo R.A. Polycystic ovaries in hirsute women with normal menses. Am J Med 111 (2001) 602-606
12. Chang P.L., Lindheim S.R., Lowre C., Ferin M., Gonzalez F., Berglund L., et al. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab 85 (2000) 995-1000
13. Rosenfield R.L., Barnes R.B., and Ehrmann D.A. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 79 (1994) 1686-1692
14. Järvelä I.Y., Sladkevicius P., Kelly S., Ojha K., Campbell S., and Nargund G. Effect of pituitary down-regulation on the ovary before in vitro fertilization as measured using three-dimensional power Doppler ultrasound. Fertil Steril 79 (2003) 1129-1135
15. Raine-Fenning N.J., Ramnarine K.V., Nordin N.M., and Campbell B.K. Quantification of blood perfusion using 3D power Doppler: an in-vitro flow phantom study. Journal of Physics: Conference Series 1 (2004) 181
16. Järvelä I.Y., Sladkevicius P., Tekay A.H., Campbell S., and Nargund G. Intraobserver and interobserver variability of ovarian volume, gray-scale and color flow indices obtained using transvaginal three-dimensional power Doppler ultrasonography. Ultrasound Obstet Gynecol 21 (2003) 277-282
17. Retamales I., Carrasco I., Troncoso J.L., Las Heras J., Devoto L., and Vega M. Morpho-functional study of human luteal cell subpopulations. Hum Reprod 9 (1994) 591-596
18. Csapo A.I., and Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv 33 (1978) 69-81
19. Wickenheisser J.K., Quinn P.G., Nelson V.L., Legro R.S., Strauss III J.F., and McAllister J.M. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 85 (2000) 2304-2311
20. Miro F., and Aspinall L.J. The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle. Hum Reprod 20 (2005) 96-100
21. Klein T.A., and Mishell D.R. Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives. Am J Obstet Gynecol 127 (1977) 585-589
22. Fraser H.M., Dickson S.E., Lunn S.F., Wulff C., Morris K.D., Carroll V.A., et al. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 141 (2000) 995-1000
23. Hazzard T.M., and Stouffer R.L. Angiogenesis in ovarian follicular and luteal development. Baillieres Res Clin Obstet Gynaecol 14 (2000) 883-900
24. Sugino N., Kashida S., Takiguchi S., Karube A., and Kato H. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 85 (2000) 3919-3924
25. Wulff C., Wilson H., Rudge J.S., Wiegand S.J., Lunn S.F., and Fraser H.M. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). J Clin Endocrinol Metab 86 (2001) 3377-3386
26. Wulff C., Dickson S.E., Duncan W.C., and Fraser H.M. Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod 16 (2001) 2515-2524
27. Fraser H.M., Wilson H., Morris K.D., Swanston I., and Wiegand S.J. Vascular endothelial growth factor trap suppresses ovarian function at all stages of the luteal phase in the macaque. J Clin Endocrinol Metab 90 (2005) 5811-5818 Epub 2005 Jul 26
28. Fraser H.M., Bell J., Wilson H., Taylor P.D., Morgan K., Anderson R.A., et al. Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 90 (2005) 427-434 Epub 2004 Oct 13
29. Molskness T.A., Stouffer R.L., Burry K.A., Gorrill M.J., Lee D.M., and Patton P.E. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women. Hum Reprod 19 (2004) 822-830 Epub 2004 Feb 12
30. Dharmarajan A.M., Bruce N.W., and Meyer G.T. Quantitative ultrastructural characteristics relating to transport between luteal cell cytoplasm and blood in the corpus luteum of the pregnant rat. Am J Anat 172 (1985) 87-99
31. Miyazaki T., Tanaka M., Miyakoshi K., Minegishi K., Kasai K., and Yoshimura Y. Power and colour Doppler ultrasonography for the evaluation of the vasculature of the human corpus luteum. Hum Reprod 13 (1998) 2836-2841
32. Goodman A.L., and Hodgen G.D. Antifolliculogenic action of progesterone despite hypersecretion of FSH in monkeys. Am J Physiol 243 (1982) E387-E397